Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides? (vol 13, 921483, 2022)

被引：0

作者：

de la Lastra, Jose M. Perez ^{[1
]}

Anand, Uttpal ^{[2
]}

Gonzalez-Acosta, Sergio ^{[1
]}

Lopez, Manuel R. ^{[1
]}

Dey, Abhijit ^{[3
]}

Bontempi, Elza ^{[4
,5
]}

delaNuez, Antonio Morales ^{[1
]}

机构：

[1] IPNA CSIC, Inst Prod Nat & Agrobiol, Biotechnol Macromol, San Cristobal De La Lagu, Spain

[2] CytoGene Res & Dev LLP, Barabanki, Uttar Pradesh, India

[3] Presidency Univ, Dept Life Sci, Kolkata, India

[4] Univ Brescia, Dept Mech & Ind Engn, Natl Interuniv Consortium Mat Sci & Technol INSTM, Brescia, Italy

[5] Univ Brescia, Dept Mech & Ind Engn, Chem Technol Lab, Brescia, Italy

来源：

FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷

关键词：

SARS-CoV-2; antibiotic resistance; one health approach; global health; antibiotic discovery; antimicrobial peptides; environmental contamination; vaccination;

D O I：

10.3389/fimmu.2024.1365827

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页数：1